SCHEMBL135664

SCHEMBL135664

COc1cccc(C(=O)c2c(N)sc3c2CCCC3)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.73
MAPT P10636 4/20 0.73
LMNA P02545 2/20 0.67
HPGD P15428 2/20 0.67
GAA P10253 1/20 0.67
FLT3 P36888 2/20 0.64
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
NOD1 Q9Y239 1/20 0.62
TDP1 Q9NUW8 1/20 0.57
ADORA1 P30542 1/20 0.54
RXFP1 Q9HBX9 1/20 0.53
NPC1 O15118 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
KDM4E B2RXH2 1/20 0.50
USP2 O75604 1/20 0.50
HSD17B10 Q99714 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL140059 0.85 MAPT (1.00) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL4060800 0.84 TDP1 (0.71) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL134129 0.82 ALDH1A1 (0.73) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL3773567 0.82 ALDH1A1 (0.73) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL134640 0.82 MEN1 (0.67) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL1637546 0.81 ALDH1A1 (1.00) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL135663 0.81 RXFP1 (0.65) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL4144407 0.81 ALDH1A1 (0.71) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL135885 0.81 MEN1 (0.65) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL141125 0.80 MAPT (0.66) ALDH1A1MAPTLMNAHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430029-B1 THIENO[2,3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS UNIV LEUVEN KATH (BE) 2018-01-10 EP disclosed
US-9499563-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-11-22 US disclosed
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS CISTIM LEUVEN VZW (BE) 2014-10-02 US disclosed
US-8785638-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-07-22 US disclosed
EP-2430029-A1 THIENO [2, 3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven (BE) 2012-03-21 EP disclosed
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-03-08 US disclosed
WO-2010130842-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS ALDH1A1 1925/4885MAPT 2061/4885LMNA 3907/4885
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS ALDH1A1 1925/4885MAPT 2061/4885LMNA 3907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.